Filing Details

Accession Number:
0001181431-13-026213
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 16:18:04
Reporting Period:
2013-05-07
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 16:18:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108205 Curis Inc CRIS Biological Products, (No Disgnostic Substances) (2836) 043505116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190121 R Daniel Passeri 4 Maguire Road
Lexington MA 02421
Ceo And Director No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-07 188,148 $2.43 338,898 No 4 M Direct
Common Stock Disposition 2013-05-07 100,000 $3.60 238,898 No 4 F Direct
Common Stock Disposition 2013-05-07 40,000 $3.63 198,898 No 4 S Direct
Common Stock Acquisiton 2013-05-08 86,852 $2.43 285,750 No 4 M Direct
Common Stock Disposition 2013-05-08 86,852 $3.70 198,898 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock option Disposition 2013-05-07 136,933 $0.00 40,000 $2.43
Common Stock Incentive stock option Disposition 2013-05-07 51,215 $0.00 51,215 $2.43
Common Stock Non-qualified stock option Disposition 2013-05-08 86,852 $0.00 86,852 $2.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
86,852 2007-05-13 2013-05-13 No 4 M Direct
0 2007-05-13 2013-05-13 No 4 M Direct
0 2007-05-13 2013-05-13 No 4 M Direct
Footnotes
  1. These shares were sold between $3.58-$3.71/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
  2. Options vested over a four-year period and became fully vested on May 13, 2007.
  3. These shares were sold between $3.61-$3.85/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.